- Home
- ONCY vs GDO Comparison
ONCY vs GDO Comparison
Compare ONCY & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- GDO
- Stock Information
- Founded
- ONCY 1998
- GDO 2009
- Country
- ONCY Canada
- GDO United States
- Employees
- ONCY N/A
- GDO N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- GDO Finance Companies
- Sector
- ONCY Health Care
- GDO Finance
- Exchange
- ONCY Nasdaq
- GDO Nasdaq
- Market Cap
- ONCY 89.7M
- GDO 90.2M
- IPO Year
- ONCY 1999
- GDO N/A
- Fundamental
- Price
- ONCY $1.36
- GDO $12.03
- Analyst Decision
- ONCY Strong Buy
- GDO
- Analyst Count
- ONCY 5
- GDO 0
- Target Price
- ONCY $5.00
- GDO N/A
- AVG Volume (30 Days)
- ONCY 1.3M
- GDO 39.4K
- Earning Date
- ONCY 11-11-2025
- GDO 01-01-0001
- Dividend Yield
- ONCY N/A
- GDO 9.81%
- EPS Growth
- ONCY N/A
- GDO N/A
- EPS
- ONCY N/A
- GDO N/A
- Revenue
- ONCY N/A
- GDO N/A
- Revenue This Year
- ONCY N/A
- GDO N/A
- Revenue Next Year
- ONCY N/A
- GDO N/A
- P/E Ratio
- ONCY N/A
- GDO N/A
- Revenue Growth
- ONCY N/A
- GDO N/A
- 52 Week Low
- ONCY $0.33
- GDO $11.21
- 52 Week High
- ONCY $1.53
- GDO $13.04
- Technical
- Relative Strength Index (RSI)
- ONCY 64.50
- GDO 59.64
- Support Level
- ONCY $1.20
- GDO $11.99
- Resistance Level
- ONCY $1.44
- GDO $12.12
- Average True Range (ATR)
- ONCY 0.11
- GDO 0.08
- MACD
- ONCY 0.01
- GDO 0.01
- Stochastic Oscillator
- ONCY 81.40
- GDO 66.67
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.